C.C. Abbou

Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

Jean‐Jacques Patard, Emmanuelle Leray, Nathalie Rioux‐Leclercq et al. · Journal of Clinical Oncology · 2005 · 754 citations

Medicine, Oncology, Urology +13

Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors

C Billerey, Dominique Chopin, Marie‐Hélène Aubriot‐Lorton et al. · American Journal Of Pathology · 2001 · 484 citations

Medicine, Oncology, Urology +12

Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

Jean‐Jacques Patard, Hyung L. Kim, John S. Lam et al. · Journal of Clinical Oncology · 2004 · 420 citations

Medicine, Oncology, Surgery +17

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.

Ashraf Bakkar, Hervé Wallerand, François Radvanyi et al. · PubMed · 2003 · 272 citations

Medicine, Genetics, Oncology +15

Regional copy number–independent deregulation of transcription in cancer

Nicolas Stransky, Céline Vallot, Fabien Reyal et al. · Nature Genetics · 2006 · 253 citations

Medicine, Genetics, Molecular Genetics +10